Form 4 · Filed May 28, 2026, 08:19 PM UTC
RIGL/RIGEL PHARMACEUTICALS INC
Ali-Jackson Kamil — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 26, 2026 | S | sell | 2,500 | $29 | $72,925 | 12,625 |
Source: SEC EDGAR raw filing ↗ · Accession 0000905148-26-002724